重磅!数十万人紧急接种国产新冠灭活疫苗,零感染!世卫组织称年底前可能有新冠疫苗结果出炉

2020-09-11 39健康网 39健康网

国药集团中国生物负责人就新冠灭活疫苗紧急使用和海外III期临床研究情况接受媒体采访时透露,国药中国生物研制的两款新冠灭活疫苗紧急使用,已经接种了数十万人次,无一例明显不良反应,无一人感染;其中打完疫苗

全国新增15例确诊病例,均为境外输入

9月10日0—24时,全国新增确诊病例15例,均为境外输入病例;无新增死亡病例;无新增疑似病例。当日新增治愈出院病例19例,重症病例较前一日减少1例。境外输入现有确诊病例157例,现有疑似病例1例。累计确诊病例2619例,累计治愈出院病例2462例,无死亡病例。截至9月10日24时,全国现有确诊病例157例,累计治愈出院病例80377例,累计死亡病例4634例,累计报告确诊病例85168例。

世卫组织:全球新冠肺炎新增超25万例

当地时间9月10日,世卫组织发布全球各地区疫情数据,全球新冠肺炎确诊病例新增250003例,死亡新增4880例。疫情最为严重的美洲区域确诊病例达到14337245例(新增79574例),死亡498255例(新增2539例)。东南亚区域确诊病例超过500万例,达到5067207例(新增102259例)。(央视新闻客户端)

美国新冠病毒感染病例接近640万

据美国约翰斯·霍普金斯大学全球疫情实时监测系统显示,截至美国东部时间9月10日下午5时28分,全美共报告新冠病毒感染病例6390840例,其中包括死亡病例191612例。与该系统大约24小时前的数据相比,美国新增新冠病毒感染病例35971例,新增死亡病例1023例。美国疾病控制和预防中心10日发布的一项综合预测显示,到10月3日,美国新冠病毒感染造成的死亡病例数可能会在20.5万到21.7万之间。

世卫称目前最令人担心的是缺乏团结

当地时间9月10日,世卫组织举行新冠肺炎例行发布会,世卫组织总干事谭德塞表示,目前最令人担心的是缺乏团结,而这是病毒传播的绝佳机会,这也是为何疫情仍在扩散。需要全球团结和各国元首的领导力,才能击败病毒。(央视)

国产新冠灭活疫苗已紧急接种数十万人

国药集团中国生物负责人就新冠灭活疫苗紧急使用和海外III期临床研究情况接受媒体采访时透露,国药中国生物研制的两款新冠灭活疫苗紧急使用,已经接种了数十万人次,无一例明显不良反应,无一人感染;其中打完疫苗之后去海外高风险国家和地区的数万人,截至目前实现了零感染。(科技日报)

欧洲疫情抬头

9月,欧洲新冠疫情持续抬头。据报道,在周三新增8000多例确诊病例后,法国政府正面临着下一阶段如何抗疫的艰难决定。海峡对岸的英国每日新增病例数已超过2000例。捷克共和国周二首次出现疫情以来单日新增病例超过1000例,政府下令要求民众在室内必须佩戴口罩。(中国日报)

钟南山提醒世界疫情远远没有结束

钟南山:“从世界范围看起来,疫情远远没有结束,对我们来说任务还是很重。因为中国一个国家好,那不可能换来全世界的安宁,所以有很多的事情要做,除了中国做好以外,还有跟全世界的各国共同努力、团结,才能赢得抗疫斗争的最后胜利。”转!战疫加油!(央视新闻)

新冠肺炎治愈患者出院后可自愿接受心理测评

9月11日,国家卫健委会同民政部、公安部、司法部、全国妇联、中国残联制定的《新冠肺炎疫情防控常态化下治愈患者心理疏导工作方案》正式发布。其中明确提出,新冠肺炎治愈患者出院返回社区后可自愿接受心理测评,各地应对有服务需求的治愈患者提出心理疏导建议,且每半年至少开展一次随访。同时,治愈患者人数较多的市(地、州)要适当设置心理热线坐席,延长在线服务时间,使电话打得通、有人接。(北京日报客户端)

世卫组织:年底前可能有新冠疫苗结果出炉

当地时间9月10日,世卫组织举行新冠肺炎例行发布会,世卫组织首席科学家苏米娅·斯瓦米纳坦表示,要搜集足够的数据就需要数以万计的受试者参与临床试验,并至少持续约六个月,才能评估疫苗的有效性和安全性,可能会在年底前得到一些结果。目前大多数候选疫苗的一期和二期临床试验数据都显示出了希望,可以使人体产生中和抗体 。(央视新闻客户端)

南非总统:非洲应第一时间获取新冠疫苗

南非总统、非洲联盟轮值主席拉马福萨10日在以视频方式举行的世界卫生组织“获得抗击新冠肺炎工具加速器”倡议促进委员会首届会议上说,新冠疫苗临床试验的参与试验者应该包括非洲人,以确保这些疫苗同样适用于非洲人群。拉马福萨呼吁全世界所有国家支持正在进行的全球性新冠疫苗研发,以确保新冠疫苗能尽早问世并在世界各地广泛使用。(新华社)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2078845, encodeId=6cbd20e8845d5, content=<a href='/topic/show?id=f48865242bb' target=_blank style='color:#2F92EE;'>#活疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65242, encryptionId=f48865242bb, topicName=活疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa106, createdName=crystal0562, createdTime=Tue Oct 13 05:24:46 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004134, encodeId=e20e20041346e, content=<a href='/topic/show?id=be3298809fb' target=_blank style='color:#2F92EE;'>#零感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98809, encryptionId=be3298809fb, topicName=零感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Dec 30 13:24:46 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300903, encodeId=4bcc130090366, content=<a href='/topic/show?id=d6f720e61ab' target=_blank style='color:#2F92EE;'>#世卫组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20761, encryptionId=d6f720e61ab, topicName=世卫组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Sep 13 12:24:46 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523308, encodeId=851115233080a, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sun Sep 13 12:24:46 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549618, encodeId=0f30154961873, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Sep 13 12:24:46 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028541, encodeId=d1981028541ee, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Sep 12 00:24:46 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2078845, encodeId=6cbd20e8845d5, content=<a href='/topic/show?id=f48865242bb' target=_blank style='color:#2F92EE;'>#活疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65242, encryptionId=f48865242bb, topicName=活疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa106, createdName=crystal0562, createdTime=Tue Oct 13 05:24:46 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004134, encodeId=e20e20041346e, content=<a href='/topic/show?id=be3298809fb' target=_blank style='color:#2F92EE;'>#零感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98809, encryptionId=be3298809fb, topicName=零感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Dec 30 13:24:46 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300903, encodeId=4bcc130090366, content=<a href='/topic/show?id=d6f720e61ab' target=_blank style='color:#2F92EE;'>#世卫组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20761, encryptionId=d6f720e61ab, topicName=世卫组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Sep 13 12:24:46 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523308, encodeId=851115233080a, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sun Sep 13 12:24:46 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549618, encodeId=0f30154961873, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Sep 13 12:24:46 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028541, encodeId=d1981028541ee, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Sep 12 00:24:46 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2078845, encodeId=6cbd20e8845d5, content=<a href='/topic/show?id=f48865242bb' target=_blank style='color:#2F92EE;'>#活疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65242, encryptionId=f48865242bb, topicName=活疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa106, createdName=crystal0562, createdTime=Tue Oct 13 05:24:46 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004134, encodeId=e20e20041346e, content=<a href='/topic/show?id=be3298809fb' target=_blank style='color:#2F92EE;'>#零感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98809, encryptionId=be3298809fb, topicName=零感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Dec 30 13:24:46 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300903, encodeId=4bcc130090366, content=<a href='/topic/show?id=d6f720e61ab' target=_blank style='color:#2F92EE;'>#世卫组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20761, encryptionId=d6f720e61ab, topicName=世卫组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Sep 13 12:24:46 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523308, encodeId=851115233080a, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sun Sep 13 12:24:46 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549618, encodeId=0f30154961873, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Sep 13 12:24:46 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028541, encodeId=d1981028541ee, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Sep 12 00:24:46 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2078845, encodeId=6cbd20e8845d5, content=<a href='/topic/show?id=f48865242bb' target=_blank style='color:#2F92EE;'>#活疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65242, encryptionId=f48865242bb, topicName=活疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa106, createdName=crystal0562, createdTime=Tue Oct 13 05:24:46 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004134, encodeId=e20e20041346e, content=<a href='/topic/show?id=be3298809fb' target=_blank style='color:#2F92EE;'>#零感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98809, encryptionId=be3298809fb, topicName=零感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Dec 30 13:24:46 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300903, encodeId=4bcc130090366, content=<a href='/topic/show?id=d6f720e61ab' target=_blank style='color:#2F92EE;'>#世卫组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20761, encryptionId=d6f720e61ab, topicName=世卫组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Sep 13 12:24:46 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523308, encodeId=851115233080a, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sun Sep 13 12:24:46 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549618, encodeId=0f30154961873, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Sep 13 12:24:46 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028541, encodeId=d1981028541ee, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Sep 12 00:24:46 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2078845, encodeId=6cbd20e8845d5, content=<a href='/topic/show?id=f48865242bb' target=_blank style='color:#2F92EE;'>#活疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65242, encryptionId=f48865242bb, topicName=活疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa106, createdName=crystal0562, createdTime=Tue Oct 13 05:24:46 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004134, encodeId=e20e20041346e, content=<a href='/topic/show?id=be3298809fb' target=_blank style='color:#2F92EE;'>#零感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98809, encryptionId=be3298809fb, topicName=零感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Dec 30 13:24:46 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300903, encodeId=4bcc130090366, content=<a href='/topic/show?id=d6f720e61ab' target=_blank style='color:#2F92EE;'>#世卫组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20761, encryptionId=d6f720e61ab, topicName=世卫组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Sep 13 12:24:46 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523308, encodeId=851115233080a, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sun Sep 13 12:24:46 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549618, encodeId=0f30154961873, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Sep 13 12:24:46 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028541, encodeId=d1981028541ee, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Sep 12 00:24:46 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
    2020-09-13 xxxx1054
  6. [GetPortalCommentsPageByObjectIdResponse(id=2078845, encodeId=6cbd20e8845d5, content=<a href='/topic/show?id=f48865242bb' target=_blank style='color:#2F92EE;'>#活疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65242, encryptionId=f48865242bb, topicName=活疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa106, createdName=crystal0562, createdTime=Tue Oct 13 05:24:46 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004134, encodeId=e20e20041346e, content=<a href='/topic/show?id=be3298809fb' target=_blank style='color:#2F92EE;'>#零感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98809, encryptionId=be3298809fb, topicName=零感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Dec 30 13:24:46 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300903, encodeId=4bcc130090366, content=<a href='/topic/show?id=d6f720e61ab' target=_blank style='color:#2F92EE;'>#世卫组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20761, encryptionId=d6f720e61ab, topicName=世卫组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Sep 13 12:24:46 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523308, encodeId=851115233080a, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sun Sep 13 12:24:46 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549618, encodeId=0f30154961873, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Sep 13 12:24:46 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028541, encodeId=d1981028541ee, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Sep 12 00:24:46 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
    2020-09-12 公卫新人

    新冠肺炎,疫情何时才能消失

    0

相关资讯

陈薇带来好消息!重组新冠疫苗能有效覆盖病毒变异

“人民英雄”国家荣誉称号获得者、中国工程院院士、军事科学院军事医学研究院研究员陈薇,带领团队研发重组新冠疫苗,在国内和国际分别率先进入I期、Ⅱ期临床试验,该疫苗Ⅲ期国际临床试验

今日要闻:日本同意购买AZ新冠疫苗,药明开展疫苗的CDMO业务

在与辉瑞和BioNTech签署COVID-19疫苗供应协议后不久,日本也同意从阿斯利康购买。而该国将从武田公司获得更多的供应,因为日本制药公司将负责诺瓦克斯的疫苗在当地的供应。三星生物的目标是在202

赛诺菲/GSK启动新冠疫苗I/II期研究

9月3日,赛诺菲/GSK宣布启动佐剂新冠疫苗的I/II期临床试验。该项研究采用随机、双盲、安慰剂对照设计,计划在美国的11个研究中心入组440例健康受试者,主要评估疫苗的安全性、耐受性和免疫原性。

陈薇团队新冠疫苗海外开展三期临床试验

为了隆重表彰在抗击新冠肺炎疫情斗争中作出杰出贡献的功勋模范人物,张伯礼、张定宇、陈薇被授予“人民英雄”国家荣誉称号。

万泰生物「鼻喷流感病毒载体新冠肺炎疫苗」启动 I 期临床试验

9月9日,万泰生物发布公告称其与厦门大学、香港大学合作研发的鼻喷流感病毒载体新冠肺炎疫苗在中国启动 I 期临床研究,用于评估新冠疫苗的安全性,并探索其免疫原性。该疫苗目前已投入研发费用525.44万元